Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 16 items for :

  • pegvisomant x
Clear All
Antonella Giampietro Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for other papers by Antonella Giampietro in
Google Scholar
PubMed Close
,
Sabrina Chiloiro Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for other papers by Sabrina Chiloiro in
Google Scholar
PubMed Close
,
Claudio Urbani Endocrinology II Unit, Department of Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy

Search for other papers by Claudio Urbani in
Google Scholar
PubMed Close
,
Rosario Pivonello Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Rosario Pivonello in
Google Scholar
PubMed Close
,
Martin Ove Carlsson Global Medical Affairs, Pfizer Rare Disease, Brussels, Belgium

Search for other papers by Martin Ove Carlsson in
Google Scholar
PubMed Close
,
Francesca Dassie Department of Medicine - DIMED, University of Padua, Padua, Italy

Search for other papers by Francesca Dassie in
Google Scholar
PubMed Close
,
Nunzia Prencipe Division of Endocrinology, Diabetology and Metabolism, Department of Medical Science, University of Turin, Turin, Italy

Search for other papers by Nunzia Prencipe in
Google Scholar
PubMed Close
,
Marta Ragonese Unit of Endocrinology, Department of Human Pathology, University of Messina, Messina, Italy

Search for other papers by Marta Ragonese in
Google Scholar
PubMed Close
,
Roy Gomez Global Medical Affairs, Pfizer Rare Disease, Brussels, Belgium

Search for other papers by Roy Gomez in
Google Scholar
PubMed Close
,
Simona Granato Medical Department, Pfizer Italia, Rome, Italy

Search for other papers by Simona Granato in
Google Scholar
PubMed Close
,
Salvatore Cannavò Unit of Endocrinology, Department of Human Pathology, University of Messina, Messina, Italy

Search for other papers by Salvatore Cannavò in
Google Scholar
PubMed Close
,
Silvia Grottoli Division of Endocrinology, Diabetology and Metabolism, Department of Medical Science, University of Turin, Turin, Italy

Search for other papers by Silvia Grottoli in
Google Scholar
PubMed Close
,
Pietro Maffei Department of Medicine - DIMED, University of Padua, Padua, Italy

Search for other papers by Pietro Maffei in
Google Scholar
PubMed Close
,
Annamaria Colao Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Annamaria Colao in
Google Scholar
PubMed Close
,
Fausto Bogazzi Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Fausto Bogazzi in
Google Scholar
PubMed Close
, and
Antonio Bianchi Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for other papers by Antonio Bianchi in
Google Scholar
PubMed Close

inconsistent between studies, and this topic is open to discussion. Thus, the aim of this analysis was to examine which factors are associated with the achievement of disease control using data from ACROSTUDY, a large international study of pegvisomant

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0247
Volume/Issue:
Volume 13: Issue 3
Open access
Hélène Lasolle Fédération d’Endocrinologie, Centre de Référence Maladies Rares Hypophysaires HYPO, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France

Search for other papers by Hélène Lasolle in
Google Scholar
PubMed Close
,
Amandine Ferriere Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France

Search for other papers by Amandine Ferriere in
Google Scholar
PubMed Close
,
Alexandre Vasiljevic Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France
Centre de Pathologie et de Neuropathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France

Search for other papers by Alexandre Vasiljevic in
Google Scholar
PubMed Close
,
Sandrine Eimer UFR Sciences médicales, Université de Bordeaux, Bordeaux, France
Service d’anatomo-pathologie, Hopital Pellegrin, CHU de Bordeaux, Bordeaux, France

Search for other papers by Sandrine Eimer in
Google Scholar
PubMed Close
,
Marie-Laure Nunes Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France

Search for other papers by Marie-Laure Nunes in
Google Scholar
PubMed Close
, and
Antoine Tabarin Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France

Search for other papers by Antoine Tabarin in
Google Scholar
PubMed Close

, pegvisomant (PEG), is a second-line treatment which normalizes IGF-1 plasma levels in 60–70% ( 5 ) of patients in follow-up registries and up to 97% in single-center series ( 6 ). The dopamine D2-receptor agonist, cabergoline, is an alternative to 1 GSSA

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0332
Volume/Issue:
Volume 8: Issue 10
Open access
Bernardo Maia Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Bernardo Maia in
Google Scholar
PubMed Close
,
Leandro Kasuki Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil

Search for other papers by Leandro Kasuki in
Google Scholar
PubMed Close
, and
Mônica R Gadelha Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil

Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed Close

Pegvisomant (4, 24) GHR antagonist 10–40 mg/day, SC 70 No effect Injection-site reactions, elevated liver enzymes GHR, growth hormone receptor; IM, intramuscular; SC, subcutaneous; SST, somatostatin receptor. Somatostatin

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0433
Volume/Issue:
Volume 9: Issue 12
Open access
Julie M Silverstein Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8127, St Louis, Missouri 63110, USA

Search for other papers by Julie M Silverstein in
Google Scholar
PubMed Close

, there is no evidence of this association in patients with acromegaly who are treated with lower doses (38, 39) . As observed with SSAs, gastrointestinal discomfort is the AE most widely reported to be associated with cabergoline (40) . Pegvisomant is a

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-15-0064
Volume/Issue:
Volume 4: Issue 4
Open access
Peter Wolf Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Peter Wolf in
Google Scholar
PubMed Close
,
Alexandre Dormoy Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed Close
,
Luigi Maione Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Luigi Maione in
Google Scholar
PubMed Close
,
Sylvie Salenave Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Sylvie Salenave in
Google Scholar
PubMed Close
,
Jacques Young Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Jacques Young in
Google Scholar
PubMed Close
,
Peter Kamenický Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Peter Kamenický in
Google Scholar
PubMed Close
, and
Philippe Chanson Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close

pegvisomant both improve insulin sensitivity ( 6 ), glucose metabolism may improve or worsen when patients are treated with first-generation somatostatin receptor ligands (SRLs), octreotide and lanreotide ( 7 , 8 , 9 , 10 ). Pasireotide is a somatostatin

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0296
Volume/Issue:
Volume 11: Issue 12
Open access
Cecilia Follin Department of Endocrinology, Skåne University Hospital, Lund, Sweden

Search for other papers by Cecilia Follin in
Google Scholar
PubMed Close
and
Sven Karlsson Department of Endocrinology, Skåne University Hospital, Lund, Sweden

Search for other papers by Sven Karlsson in
Google Scholar
PubMed Close

remnant tissue and thus lead to reduced IGF-1 levels and reduced symptoms ( 6 , 7 ). A GH-receptor antagonist (e.g. pegvisomant) is also an option, and such drugs block the effects of GH at the level of the GH receptor and also reduce IGF-1 levels and

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0038
Volume/Issue:
Volume 5: Issue 4
Open access
Adrian F Daly Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Adrian F Daly in
Google Scholar
PubMed Close
,
Liliya Rostomyan Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed Close
,
Daniela Betea Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Daniela Betea in
Google Scholar
PubMed Close
,
Jean-François Bonneville Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed Close
,
Chiara Villa Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium
Department of Pathological Cytology and Anatomy, Foch Hospital, Paris, France

Search for other papers by Chiara Villa in
Google Scholar
PubMed Close
,
Natalia S Pellegata Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany

Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed Close
,
Beatrice Waser Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Beatrice Waser in
Google Scholar
PubMed Close
,
Jean-Claude Reubi Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Jean-Claude Reubi in
Google Scholar
PubMed Close
,
Catherine Waeber Stephan Clinique Générale Ste-Anne, Fribourg, Switzerland

Search for other papers by Catherine Waeber Stephan in
Google Scholar
PubMed Close
,
Emanuel Christ Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, University of Basel, Basel, Switzerland

Search for other papers by Emanuel Christ in
Google Scholar
PubMed Close
, and
Albert Beckers Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Albert Beckers in
Google Scholar
PubMed Close

-generation somatostatin analogs in patients with AIP mutations, the role of other agents such as the GH receptor antagonist pegvisomant has been described in those with AIP mutations ( 14 ). Pasireotide is a newer somatostatin analog that is approved for use in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0004
Volume/Issue:
Volume 8: Issue 4
Open access
Nelma Veronica Marques Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed Close
,
Luiz Eduardo Armondi Wildemberg Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed Close
, and
Monica R Gadelha Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Monica R Gadelha in
Google Scholar
PubMed Close

/or cabergoline. Patients were not suitable for another surgical intervention because MRI did not show a clear residual lesion or showed a lesion that could not be resected. Pegvisomant is not available in the public health service in our country, and treatment

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0155
Volume/Issue:
Volume 12: Issue 10
Open access
Gudmundur Johannsson Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed Close
,
Martin Bidlingmaier Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed Close
,
Beverly M K Biller Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed Close
,
Margaret Boguszewski Federal University of Parana, Curitiba, Brazil

Search for other papers by Margaret Boguszewski in
Google Scholar
PubMed Close
,
Felipe F Casanueva Department of Medicine, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain

Search for other papers by Felipe F Casanueva in
Google Scholar
PubMed Close
,
Philippe Chanson Assistance Publique-Hôpitaux de Paris, and Inserm, Paris, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close
,
Peter E Clayton Developmental Biology & Medicine, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK

Search for other papers by Peter E Clayton in
Google Scholar
PubMed Close
,
Catherine S Choong Department of Endocrinology, Princess Margaret Hospital & School of Medicine, University of Western Australia, Western Australia, Australia

Search for other papers by Catherine S Choong in
Google Scholar
PubMed Close
,
David Clemmons Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA

Search for other papers by David Clemmons in
Google Scholar
PubMed Close
,
Mehul Dattani Great Ormond Street Institute of Child Health, London, UK

Search for other papers by Mehul Dattani in
Google Scholar
PubMed Close
,
Jan Frystyk Department of Endocrinology, Odense University Hospital, Odense, Denmark

Search for other papers by Jan Frystyk in
Google Scholar
PubMed Close
,
Ken Ho Princess Alexandra Hospital and University of Queensland, Brisbane, Australia

Search for other papers by Ken Ho in
Google Scholar
PubMed Close
,
Andrew R Hoffman Department of Medicine, Stanford University and VA Palo Health Care System, Palo Alto, California, USA

Search for other papers by Andrew R Hoffman in
Google Scholar
PubMed Close
,
Reiko Horikawa National Center for Child Health and Development, Tokyo, Japan

Search for other papers by Reiko Horikawa in
Google Scholar
PubMed Close
,
Anders Juul Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed Close
,
John J Kopchick Edison Biotechnology Institute and Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA

Search for other papers by John J Kopchick in
Google Scholar
PubMed Close
,
Xiaoping Luo Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Search for other papers by Xiaoping Luo in
Google Scholar
PubMed Close
,
Sebastian Neggers Section of Endocrinology, Department of Medicine, Pituitary Centre Rotterdam, Erasmus University Medical Centre, Rotterdam, the Netherlands

Search for other papers by Sebastian Neggers in
Google Scholar
PubMed Close
,
Irene Netchine Service d’Explorations Fonctionnelles Endocriniennes, AP-HP, Hôpital Trousseau, Sorbonne Université, INSERM UMRs 938, Paris, France

Search for other papers by Irene Netchine in
Google Scholar
PubMed Close
,
Daniel S Olsson Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Daniel S Olsson in
Google Scholar
PubMed Close
,
Sally Radovick Rutgers University-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

Search for other papers by Sally Radovick in
Google Scholar
PubMed Close
,
Ron Rosenfeld Department of Pediatrics, Oregon Health Science University, Portland, Oregon, USA

Search for other papers by Ron Rosenfeld in
Google Scholar
PubMed Close
,
Richard J Ross University of Sheffield, Sheffield, UK

Search for other papers by Richard J Ross in
Google Scholar
PubMed Close
,
Katharina Schilbach Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Katharina Schilbach in
Google Scholar
PubMed Close
,
Paulo Solberg Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Paulo Solberg in
Google Scholar
PubMed Close
,
Christian Strasburger Charité-Universitätsmedizin, Berlin, Germany

Search for other papers by Christian Strasburger in
Google Scholar
PubMed Close
,
Peter Trainer The Christie NHS Foundation Trust, University of Manchester, Manchester, UK

Search for other papers by Peter Trainer in
Google Scholar
PubMed Close
,
Kevin C J Yuen Barrow Pituitary Center, Barrow Neurological Institute, Department of Neuroendocrinology, University of Arizona College of Medicine, Phoenix, Arizona, USA

Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed Close
,
Kerstin Wickstrom Medical Products Agency, Uppsala, Sweden

Search for other papers by Kerstin Wickstrom in
Google Scholar
PubMed Close
,
Jens O L Jorgensen Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Jens O L Jorgensen in
Google Scholar
PubMed Close
, and
on behalf of the Growth Hormone Research Society
Search for other papers by on behalf of the Growth Hormone Research Society in
Google Scholar
PubMed Close

AJ Dimaraki EV Stewart PM Friend KE Vance ML , et al . Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant . New England Journal of Medicine 2000 342 1171 – 1177 . ( https://doi.org/10.1056/NEJM200004203421604 ) 10

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0047
Volume/Issue:
Volume 7: Issue 3
Open access
Adrian F Daly Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Adrian F Daly in
Google Scholar
PubMed Close
,
David A Cano Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by David A Cano in
Google Scholar
PubMed Close
,
Eva Venegas-Moreno Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Eva Venegas-Moreno in
Google Scholar
PubMed Close
,
Patrick Petrossians Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Patrick Petrossians in
Google Scholar
PubMed Close
,
Elena Dios Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Elena Dios in
Google Scholar
PubMed Close
,
Emilie Castermans Department of Human Genetics, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Emilie Castermans in
Google Scholar
PubMed Close
,
Alvaro Flores-Martínez Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Alvaro Flores-Martínez in
Google Scholar
PubMed Close
,
Vincent Bours Department of Human Genetics, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Vincent Bours in
Google Scholar
PubMed Close
,
Albert Beckers Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Albert Beckers in
Google Scholar
PubMed Close
, and
Alfonso Soto-Moreno Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Alfonso Soto-Moreno in
Google Scholar
PubMed Close

. Pituitary 2015 18 803 – 807 . ( https://doi.org/10.1007/s11102-015-0655-4 ) 25893613 10.1007/s11102-015-0655-4 4 Neggers SJCMM de Herder WW Feelders RA van der Lely AJ. Conversion of daily pegvisomant to weekly pegvisomant combined with long

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0027
Volume/Issue:
Volume 8: Issue 4
Open access